ask why
Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

The papers that matter: 16 November to 22 November 2026

This week so far. The 10 most important of the 14 papers published that week and summarised on Y, ranked by what verified readers said would change practice, then by strength of design and size. Secondary analyses come last.
Palliative and end-of-life care · Support Care Cancer · 2026-11-16

In a stepped wedge trial of 2348 distressed patients and caregivers calling a cancer telephone support service, structured distress screening and referral did not increase referral uptake or reduce distress versus usual care; intervention fidelity was poor.

RCTn = 2,348
Fradgley et al. The impact of structured care versus usual care on service uptake and distress among distressed callers to a cancer telephone support service: outcomes of the START stepped wedge trial
Dermatology · Acta Derm Venereol · 2026-11-17

Meta-analysis of 14 observational studies (464 biologic treatment lines) in pityriasis rubra pilaris: pooled complete/near-complete response 0.36, any response 0.73. No significant difference between TNF, IL-17 and IL-23 pathway inhibitor classes (p=0.057); AEs in 12/183 courses.

Meta-analysisn = 464 biologic therapeutic lines
Tartaglia et al. Biologic Therapy in Pityriasis Rubra Pilaris: Systematic Review and Meta-analysis with Class-based Comparisons
Infectious diseases · J Infect Dis · 2026-11-16

In a first-in-human trial, 51 healthy adults received single intravenous GB-0669 (100–2400 mg; n=36) or placebo (n=15). It was well tolerated with only mild adverse reactions, a half-life of 54 days, and dose-dependent virus neutralisation at 600 and 1200 mg.

RCTn = 51
Borriello et al. Randomized, Double-Blind, Placebo-Controlled First-in-Human Trial of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem Helix

Previous weekAll weeks

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.